LUXEMBOURG, January 19, 2026--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 12/01/2026 | FR0014000MR3 | 10 000 | 70.5975 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 13/01/2026 | FR0014000MR3 | 5 000 | 72.9633 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 14/01/2026 | FR0014000MR3 | 5 000 | 72.6177 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 15/01/2026 | FR0014000MR3 | 5 000 | 72.2203 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 16/01/2026 | FR0014000MR3 | 5 000 | 72.4636 | XPAR |
TOTAL | 30 000 | 71.9100 |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20260119511422/en/
Contacts
Eurofins